Search Results - Marbury T

A risk-based approach to validation of ion chromatography methods using suppressed conductivity by Deanna J. Nelson, G. Dean Marbury

Connect to this object online.

Pharmacokinetics of conivaptan use in patients with severe hepatic impairment by Marbury T, Fox J, Kaelin B, Pavliv L

Connect to this object online.

Pharmacokinetic profile of defibrotide in patients with renal impairment by Tocchetti P, Tudone E, Marier JF, Marbury TC, Zomorodi K, Eller M

Connect to this object online.

A phase I, open‐label, single‐dose study to evaluate the effect of hepatic impairment on the pharmacokinetics and safety of futibatinib by Ling Gao, Ikuo Yamamiya, Mark Pinti, Juan Carlos Rondon, Thomas Marbury, Gareth Tomlinson, Lukas Makris, Nanae Hangai, Volker Wacheck

Connect to this object online.

Reduced hepatic impairment study to evaluate pharmacokinetics and safety of zavegepant and to inform dosing recommendation for hepatic impairment by Rajinder Bhardwaj, Mary K. Donohue, Jennifer Madonia, Beth Morris, Thomas C. Marbury, Kyle T. Matschke, Robert Croop, Richard Bertz, Jing Liu

Connect to this object online.

Phase 1 pharmacokinetic and safety study of soticlestat in participants with mild or moderate hepatic impairment or normal hepatic function by Wei Yin, Pranab Mitra, Veronique Copalu, Thomas C. Marbury, Juan Carlos Rondon, Eric J. Lawitz, Valerie Lloyd, Mike Baratta, Mahnaz Asgharnejad, Tom Hui, Yasir Khan

Connect to this object online.